Summit Trail Advisors’s Omnicell OMCL Stock Holding History

Summit Trail Advisors’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-88	Closed	-$4K	–	1283
2017 Q4	$4K	Buy	+88	New	+$4.44K	﹤0.01%	1480

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Summit Trail Advisors's OMCL Position: Q1 2018 in Review

Summit Trail Advisors sold out of Omnicell (OMCL) in Q1 2018, closing a stake of 88 shares — an estimated $4K sold.

Summit Trail Advisors first reported a position in OMCL in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 231 funds tracked by Wall St. Rank hold OMCL as of Q1 2018.

Summit Trail Advisors reported no remaining Omnicell position as of Q1 2018 after selling out during the quarter.
Summit Trail Advisors sold 88 Omnicell shares in Q1 2018, an estimated $4K.
Summit Trail Advisors first reported a position in Omnicell in Q4 2017 and held it in 1 quarter.
Summit Trail Advisors's Omnicell position peaked at $4K in Q4 2017.
231 funds tracked by Wall St. Rank held Omnicell as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.